Neumann Mark
SEC insider (Form 3/4/5 filer). CIK 0001756211. Chief Commercial Officer at Veradermics, Inc (MANE) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Feb 3, 2026. Located in NEW HAVEN, CT.
Companies Neumann Mark has filed insider reports for
- Veradermics, Inc (MANE): Officer, Chief Commercial Officer
- Intra-Cellular Therapies, Inc. (ITCI): Officer, EVP, Chief Commercial Officer
Neumann Mark
CIK: 0001756211
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Feb 3, 2026MANE
Veradermics, Inc
AwardDirectStock Option (Right to Buy)
102.9K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
DispositionDirect52.8K shares at avg. $132.00$7.0M - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
AwardDirectPerformance Stock Units
13.1K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
AwardDirectPerformance Stock Units
8.7K shares- - Mar 10, 2025ITCI
Intra-Cellular Therapies, Inc.
Tax PaymentDirect3.1K shares at avg. $131.24$409K - Mar 10, 2025ITCI
Intra-Cellular Therapies, Inc.
ExerciseDirect7.3K shares- - Mar 6, 2025ITCI
Intra-Cellular Therapies, Inc.
ExerciseDirect13.1K shares- - Mar 6, 2025ITCI
Intra-Cellular Therapies, Inc.
Tax PaymentDirect5.6K shares at avg. $131.19$731K - Mar 1, 2025ITCI
Intra-Cellular Therapies, Inc.
ExerciseDirect8.7K shares- - Mar 1, 2025ITCI
Intra-Cellular Therapies, Inc.
Tax PaymentDirect3.7K shares at avg. $128.20$475K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 3, 2026 |  MANE Veradermics, Inc | Award Stock Option (Right to Buy) | 102,885 | - | - | Direct |
| Apr 2, 2025 |  ITCI Intra-Cellular Therapies, Inc. | Disposition | 52,811 | $132.00 | $6,971,052 | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award Performance Stock Units | 13,134 | - | - | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award Performance Stock Units | 8,742 | - | - | Direct |
| Mar 10, 2025 | ITCI Intra-Cellular Therapies, Inc. | Tax Payment | 3,116 | $131.24 | $408,944 | Direct |
| Mar 10, 2025 | ITCI Intra-Cellular Therapies, Inc. | Exercise | 7,345 | - | - | Direct |
| Mar 6, 2025 | ITCI Intra-Cellular Therapies, Inc. | Exercise | 13,133 | - | - | Direct |
| Mar 6, 2025 | ITCI Intra-Cellular Therapies, Inc. | Tax Payment | 5,572 | $131.19 | $730,991 | Direct |
| Mar 1, 2025 | ITCI Intra-Cellular Therapies, Inc. | Exercise | 8,742 | - | - | Direct |
| Mar 1, 2025 | ITCI Intra-Cellular Therapies, Inc. | Tax Payment | 3,709 | $128.20 | $475,494 | Direct |
1-10 of 13 transactions